Ketogenic diet does not promote triple-negative and luminal mammary tumor growth and metastasis in experimental mice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Ketogenic diet does not promote triple-negative and luminal mammary tumor growth and metastasis in experimental mice ; day:9 ; month:12 ; year:2023 ; pages:1-16
Clinical & experimental metastasis ; (9.12.2023), 1-16
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Grube, Meret
Dimmler, Arno
Schmaus, Anja
Saup, Rafael
Wagner, Tabea
Garvalov, Boyan K.
Sleeman, Jonathan P.
Thiele, Wilko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10585-023-10249-z
- URN
-
urn:nbn:de:101:1-2024022611133377889962
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Grube, Meret
- Dimmler, Arno
- Schmaus, Anja
- Saup, Rafael
- Wagner, Tabea
- Garvalov, Boyan K.
- Sleeman, Jonathan P.
- Thiele, Wilko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
Mouse mammary stem cells express prognostic markers for triple-negative breast cancer
Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification
Multipotent luminal mammary cancer stem cells model tumor heterogeneity
Metastatic Triple-Negative Breast Cancer
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer
Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
Mouse mammary stem cells express prognostic markers for triple-negative breast cancer
Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification
Multipotent luminal mammary cancer stem cells model tumor heterogeneity
Metastatic Triple-Negative Breast Cancer
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer
Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
Mouse mammary stem cells express prognostic markers for triple-negative breast cancer
Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification
Multipotent luminal mammary cancer stem cells model tumor heterogeneity
Metastatic Triple-Negative Breast Cancer
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer
Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer
Characterizing triple-negative breast cancer tumors